Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Return on Assets (2019 - 2025)

Historic Return on Assets for Allogene Therapeutics (ALLO) over the last 7 years, with Q3 2025 value amounting to 0.46%.

  • Allogene Therapeutics' Return on Assets fell 200.0% to 0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.43% for FY2024, which is 100.0% up from last year.
  • As of Q3 2025, Allogene Therapeutics' Return on Assets stood at 0.46%, which was down 200.0% from 0.48% recorded in Q2 2025.
  • Allogene Therapeutics' 5-year Return on Assets high stood at 0.17% for Q4 2021, and its period low was 0.48% during Q2 2025.
  • Over the past 5 years, Allogene Therapeutics' median Return on Assets value was 0.44% (recorded in 2023), while the average stood at 0.36%.
  • In the last 5 years, Allogene Therapeutics' Return on Assets skyrocketed by 1000bps in 2021 and then plummeted by -2200bps in 2022.
  • Over the past 5 years, Allogene Therapeutics' Return on Assets (Quarter) stood at 0.17% in 2021, then crashed by -130bps to 0.39% in 2022, then decreased by -18bps to 0.46% in 2023, then rose by 2bps to 0.45% in 2024, then fell by -3bps to 0.46% in 2025.
  • Its Return on Assets stands at 0.46% for Q3 2025, versus 0.48% for Q2 2025 and 0.47% for Q1 2025.